162 related articles for article (PubMed ID: 16619249)
1. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
[TBL] [Abstract][Full Text] [Related]
2. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
[TBL] [Abstract][Full Text] [Related]
3. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
4. [Expression of antigen CD40 and survivin gene and their clinical implications in acute myeloid leukemia].
Zhu FB; Wang SY; Zhang YW
Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):769-72. PubMed ID: 15631832
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
Adida C; Recher C; Raffoux E; Daniel MT; Taksin AL; Rousselot P; Sigaux F; Degos L; Altieri DC; Dombret H
Br J Haematol; 2000 Oct; 111(1):196-203. PubMed ID: 11091201
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
8. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
10. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.
Tamm I; Richter S; Scholz F; Schmelz K; Oltersdorf D; Karawajew L; Schoch C; Haferlach T; Ludwig WD; Wuchter C
Hematol J; 2004; 5(6):489-95. PubMed ID: 15570290
[TBL] [Abstract][Full Text] [Related]
11. [Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance].
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Bull Cancer; 2005 Mar; 92(3):219-26. PubMed ID: 15820916
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
[TBL] [Abstract][Full Text] [Related]
13. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D
Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905
[TBL] [Abstract][Full Text] [Related]
14. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
[TBL] [Abstract][Full Text] [Related]
15. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
[TBL] [Abstract][Full Text] [Related]
16. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
[TBL] [Abstract][Full Text] [Related]
17. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy.
Boidot R; Vegran F; Lizard-Nacol S
Int J Mol Med; 2009 Feb; 23(2):285-91. PubMed ID: 19148555
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of apoptosis proteins in human cervical cancer.
Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S
Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
